Published in Cell Calcium on December 01, 1995
Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with cellular transformation. EMBO J (1996) 1.03
Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration. Am J Respir Cell Mol Biol (2011) 0.88
xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal (2007) 0.80
Calcium signals and FGF-2 induced neurite growth in cultured parasympathetic neurons: spatial localization and mechanisms of activation. Pflugers Arch (2013) 0.80
Fbxl12 triggers G1 arrest by mediating degradation of calmodulin kinase I. Cell Signal (2013) 0.76
Calyculin A from Discodermia calyx is a dual action toxin that blocks calcium influx and inhibits protein Ser/Thr phosphatases. Toxins (Basel) (2012) 0.76
Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol (1984) 2.33
Effect of microtubular or translational inhibitors on general cell protein degradation. Evidence for a dual catabolic pathway. Biochem J (1977) 1.93
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis (1993) 1.80
Cancer cachexia: from experimental models to patient management. Curr Opin Clin Nutr Metab Care (2000) 1.54
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer (2000) 1.31
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun (1999) 1.23
Studies on the structure-bound sedimentabolity of some rat liver lysosome hydrolases. Biochem J (1971) 1.23
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene (1990) 1.14
Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J (1987) 1.12
Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp Cell Res (1995) 1.12
Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest (2008) 1.11
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest (1995) 1.09
Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: correlation with activities of lysosomal proteases. J Cell Physiol (1978) 1.07
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Validation of a French health-related quality of life instrument for adolescents: the VSP-A. Qual Life Res (2000) 1.04
Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer (2001) 1.03
Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer (1993) 1.02
Structural equivalents of latency for lysosome hydrolases. Biochem J (1975) 1.02
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta (2001) 1.02
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. Curr Cancer Drug Targets (2009) 1.01
Control of cell protein degradation. Changes in activities of lysosomal proteases. Biochim Biophys Acta (1977) 1.01
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys (1993) 1.01
Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene. J Biol Chem (1991) 1.00
Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol (2001) 0.99
Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. Int J Cancer (1997) 0.99
TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene (2011) 0.99
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody. Cell Death Differ (2003) 0.96
The effect of epidermal growth factor on membrane potential. Rapid hyperpolarization followed by persistent fluctuations. J Biol Chem (1989) 0.96
Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med (2004) 0.96
Arachidonic acid mediates calcium influx induced by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. Cell Calcium (1997) 0.95
Zinc-containing bioactive glasses: surface reactivity and behaviour towards endothelial cells. Acta Biomater (2008) 0.95
c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Int J Cancer (1991) 0.93
Cell protein degradation in cultured rat embryo fibroblasts. Suppression by vinblastine of the enhanced proteolysis by serum-deficient media. Biochim Biophys Acta (1976) 0.92
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine (2002) 0.92
Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines. Endocrinology (2001) 0.91
Differential segregation of human and hamster cathepsin D in transfected baby-hamster kidney cells. Biochem J (1991) 0.89
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J (1994) 0.88
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol (2005) 0.87
Changes induced by fasting and cycloheximide in the vacuolar apparatus of rat hepatocytes. A morphometric investigation. Boll Soc Ital Biol Sper (1979) 0.87
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun (1996) 0.87
Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide. Biochem J (1982) 0.87
Calcium influx, arachidonic acid,and control of endothelial cell proliferation. Cell Calcium (2001) 0.86
Acute hemorrhagic pancreatic necrosis in mice: the activity of lysosomal enzymes in the pancreas and the liver. Am J Pathol (1980) 0.86
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) (1994) 0.86
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radic Biol Med (1996) 0.86
Differentiation-dependent autophagy controls the fate of newly synthesized N-linked glycoproteins in the colon adenocarcinoma HT-29 cell line. Biochem J (1995) 0.85
On the structure-linked sedimentability of rat liver beta-N-acetylglucosaminidase. Biochim Biophys Acta (1971) 0.84
Biochemical and structural changes of rat liver lysosomes by ethionine. Exp Mol Pathol (1975) 0.84
Expression of protein kinase C beta1 confers resistance to TNFalpha- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells. Int J Cancer (2001) 0.84
Lysosomal involvement in liver cell vacuolation by hypoxia. Br J Exp Pathol (1969) 0.84
Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (2002) 0.83
Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci (Lond) (1995) 0.83
Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys (1987) 0.83
Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J Cell Biochem (1999) 0.83
Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res (1997) 0.83
Tissue protein turnover during liver carcinogenesis. Carcinogenesis (1993) 0.83
Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells. J Steroid Biochem Mol Biol (1992) 0.82
Health-related quality of life reported by French adolescents: a predictive approach of health status? J Adolesc Health (2001) 0.82
Cloning and expression of two ornithine decarboxylase forms from HMOA cells. Biochem J (1995) 0.82
High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma. Invasion Metastasis (1995) 0.82
Candida albicans and HIV-1 Infection. Cell Biochem Funct (2000) 0.82
Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130. Biol Chem Hoppe Seyler (1988) 0.81
Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. Cell Growth Differ (1997) 0.81
Apoptosis of L929 cells by etoposide: a quantitative and kinetic approach. Exp Cell Res (1996) 0.81
The direct effect of carbon tetrachloride on subcellular particles. Lab Invest (1966) 0.81
Altered intracellular processing and enhanced secretion of procathepsin D in a highly deviated rat hepatoma. Int J Cancer (1995) 0.81
Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer (1997) 0.81
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells. Apoptosis (2005) 0.81
erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. Int J Cancer (1994) 0.81
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression. Curr Med Chem (2010) 0.80
Hormonal control of growth factor receptor expression. Ann N Y Acad Sci (1996) 0.80
Suppression of the 'uncovering' of mannose-6-phosphate residues in lysosomal enzymes in the presence of NH4Cl. Eur J Biochem (1990) 0.80
Sustained calcium influx activated by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. J Physiol (1995) 0.80
Decreased expression of the high-mobility group protein T160 by antisense RNA impairs the growth of mouse fibroblasts. Biochimie (1997) 0.80
On diamond surface properties and interactions with neurons. Eur Phys J E Soft Matter (2009) 0.80
Regulation of protein turnover versus growth state. Studies on the mechanism(s) of initiation of acidic vacuolar proteolysis in cells of stationary ascites hepatoma. Biochem J (1988) 0.80
Potassium and calcium currents activated by foetal calf serum in Balb-c 3T3 fibroblasts. Biochim Biophys Acta (1992) 0.80
Two currents activated by epidermal growth factor in EGFR-T17 fibroblasts. Biochim Biophys Acta (1992) 0.80
Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis (1987) 0.80